School Of Medicine Basic Sciences
-
Directorships honor VUMC’s critical missions
Vanderbilt University Medical Center (VUMC) on Monday held its first Directorship Celebration to honor and support eight of its leaders in clinical care, research, education and administration. Read MoreJan 25, 2018
-
Study may point to new ways to reverse insulin resistance
Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes. Read MoreJan 25, 2018
-
Investigators eye new target for treating movement disorders
Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson’s disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported. Read MoreJan 18, 2018
-
A spicy finding
Vanderbilt researchers have discovered that curcumin — the active ingredient in the spice turmeric — needs to be metabolically activated to exert anti-inflammatory effects. Read MoreJan 16, 2018
-
Macara named ‘Pink Tie Guy’ for Komen breast cancer research
Ian Macara, PhD, Louise B. McGavock Professor and Chair of Cell and Developmental Biology and co-leader of the Signal Transduction and Chemical Biology Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the Pink Tie Guys for the Susan G. Komen Central Tennessee organization. Read MoreJan 11, 2018
-
Early drivers of gastric cancer
Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers. Read MoreAug 8, 2017
-
Investigators use light to kill microbial ‘vampires’
On July 24 Vanderbilt scientist Eric Skaar, Ph.D., MPH, summarized his group’s latest paper in a tweet: “If S. aureus is going to drink our blood like a vampire, let's kill it with sunlight.” Read MoreJul 27, 2017
-
Study identifies protein’s role in chemotherapy resistance
Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2. Read MoreJul 20, 2017
-
Shyr named chair of Department of Biostatistics
Yu Shyr, Ph.D., Harold L. Moses Professor of Cancer Research and director of the Vanderbilt Center for Quantitative Sciences, has been named chair of Vanderbilt’s Department of Biostatistics. He will assume the post Sept. 1. Read MoreJul 20, 2017
-
Drivers of breast cancer metastasis
Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported. Read MoreJul 20, 2017
-
VU scientists report a way to calm the sepsis “storm”
Researchers at Vanderbilt University Medical Center (VUMC) have found a way to calm the “genomic storm” that triggers the often-lethal consequences of sepsis. Read MoreJun 22, 2017
-
VUMC team’s discovery could lead to new diabetes treatment
High circulating glucose, the hallmark of diabetes, is linked to the disease’s most serious complications including heart disease, kidney failure, blindness and amputation. Diabetes is the sixth leading cause of death and costs the nation an estimated $322 billion a year. Restoring the action of insulin has been the traditional… Read MoreJun 15, 2017
-
Sanders named to key VUSM Basic Sciences role
Charles Sanders, Ph.D., has been named associate dean for Research in the Basic Sciences of Vanderbilt University School of Medicine. Read MoreFeb 9, 2017
-
Gene mutation discovery may hold autism clues: study
Researchers at Vanderbilt have identified what may be a genetic “smoking gun” for autism spectrum disorder (ASD) — a mutation in the gene for the critical neuronal protein CaMKII. Read MoreFeb 2, 2017
-
Sealy named to VUSM diversity leadership role
Linda Sealy, Ph.D., has been named associate dean for Diversity, Equity and Inclusion for Basic Sciences at Vanderbilt University School of Medicine. Read MoreJan 26, 2017
-
Lindsley’s drug discovery efforts land ASPET Award
Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read MoreJan 12, 2017
-
Investigational new drug for Alzheimer’s scheduled for first study in humans
Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center. Read MoreDec 27, 2016
-
Moses elected to National Academy of Inventors
Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has been named a Fellow of the National Academy of Inventors (NAI). Moses, professor and interim chair of Cancer Biology, is among 175 academic leaders named to the 2016 class of NAI Fellows. Read MoreDec 16, 2016
-
When mitochondrial genes act up
A team of Vanderbilt scientists have identified some of the methods that mutant mitochondrial DNA use to circumvent the molecular mechanisms that cells use to regulate mitochondrial activity. Read MoreJul 12, 2016